Zydus Lifesciences Ltd (CADILAHC) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally.

Total Revenue Chart for Zydus Lifesciences Ltd

Zydus Lifesciences Ltd (CADILAHC) revenue for FY2021 was INR 148.2B, a 7.3% change from FY2020. Zydus Lifesciences Ltd's revenue grew from INR 12.0B in 2004 to INR 148.2B in 2021 (1139.0% over 17 years). Earnings per share grew from INR 7.85 in 2014 to INR 20.84 in 2021 (165.5%). Revenue compound annual growth rate: 5-year CAGR of 8.5%, 10-year CAGR of 12.7%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.